URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Kevin Walter

Concepts (205)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Brain Neoplasms
15
1994
282
3.590
Why?
Glioma
7
1994
102
2.360
Why?
Gene Expression Regulation, Neoplastic
3
2005
254
1.220
Why?
Neovascularization, Pathologic
3
2004
97
1.130
Why?
Glioblastoma
6
2000
63
1.130
Why?
Carrier Proteins
3
2005
434
1.000
Why?
Membrane Proteins
3
2005
553
0.990
Why?
Endothelium, Vascular
3
2004
445
0.930
Why?
Tumor Markers, Biological
3
2004
228
0.920
Why?
Paclitaxel
4
1994
57
0.870
Why?
Blood-Brain Barrier
3
2003
108
0.820
Why?
Collagen
2
2005
299
0.750
Why?
Hematoma, Subdural, Acute
1
2010
1
0.730
Why?
Decompressive Craniectomy
1
2010
1
0.730
Why?
Matrix Metalloproteinase 14
1
2010
13
0.720
Why?
Spinal Cord Neoplasms
1
2009
23
0.700
Why?
SEER Program
1
2009
52
0.700
Why?
Antigens, Neoplasm
1
2009
107
0.670
Why?
Antigens, CD
1
2009
245
0.620
Why?
Magnesium Sulfate
1
2007
11
0.620
Why?
Brain Ischemia
1
2008
79
0.590
Why?
Magnesium
1
2007
137
0.580
Why?
Drug Delivery Systems
2
2003
60
0.570
Why?
Anticonvulsants
1
2007
120
0.550
Why?
Brain Injuries
1
2007
109
0.530
Why?
Hepatocyte Growth Factor
2
2000
13
0.520
Why?
Microspheres
2
2003
56
0.500
Why?
Biocompatible Materials
2
2003
64
0.480
Why?
Central Nervous System Neoplasms
1
2003
21
0.460
Why?
Radiosurgery
3
2000
74
0.430
Why?
CDC2-CDC28 Kinases
1
2002
9
0.430
Why?
Proto-Oncogene Proteins c-myc
1
2002
45
0.420
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2005
543
0.390
Why?
Cell Cycle
1
2002
248
0.380
Why?
Humans
25
1994
36400
0.360
Why?
Retrospective Studies
7
1995
2260
0.310
Why?
Treatment Outcome
7
1995
2623
0.300
Why?
In Situ Hybridization
2
2005
314
0.290
Why?
DNA-Binding Proteins
1
2002
687
0.290
Why?
Male
14
1994
19713
0.270
Why?
RNA, Messenger
3
2004
1857
0.260
Why?
Up-Regulation
2
2005
372
0.250
Why?
Glasgow Coma Scale
3
1997
51
0.250
Why?
Aged
9
2000
7272
0.240
Why?
Tissue Array Analysis
2
2009
35
0.230
Why?
Aged, 80 and over
6
2000
2513
0.220
Why?
Middle Aged
9
2000
9877
0.220
Why?
Female
10
2000
19826
0.210
Why?
Kaplan-Meier Estimate
2
2009
224
0.210
Why?
Cell Line, Tumor
2
2003
576
0.210
Why?
Adult
9
2000
11345
0.210
Why?
Brain
4
1994
1221
0.200
Why?
Vimentin
1
2011
28
0.200
Why?
Animals
8
1994
16270
0.200
Why?
Carcinoma, Pancreatic Ductal
1
2011
15
0.200
Why?
Adolescent
3
2007
4752
0.190
Why?
Rats, Inbred F344
3
1994
362
0.190
Why?
Analysis of Variance
3
2000
725
0.190
Why?
Pancreatic Neoplasms
1
2011
84
0.180
Why?
Receptors, CXCR
1
2010
3
0.180
Why?
Aortic Valve Stenosis
1
2010
22
0.180
Why?
Peroxidase
1
2010
35
0.180
Why?
Dacarbazine
1
2010
21
0.180
Why?
Central Nervous System
1
2011
117
0.180
Why?
Antineoplastic Agents
1
1995
625
0.180
Why?
Xenograft Model Antitumor Assays
1
2009
46
0.180
Why?
Antineoplastic Agents, Alkylating
1
2010
41
0.180
Why?
Immunohistochemistry
2
2009
1063
0.180
Why?
Transcription, Genetic
2
2002
815
0.180
Why?
Extracellular Matrix Proteins
1
2010
74
0.170
Why?
Culture Media, Conditioned
2
2005
64
0.170
Why?
Mice, Nude
1
2009
177
0.170
Why?
Reoperation
1
2010
186
0.170
Why?
Fluorescent Antibody Technique
1
2009
291
0.170
Why?
Catheterization
1
2010
127
0.170
Why?
Chi-Square Distribution
1
2010
333
0.160
Why?
Protein-Serine-Threonine Kinases
2
2000
285
0.160
Why?
Survival Analysis
6
1994
598
0.160
Why?
Aneurysm, Ruptured
2
1997
9
0.160
Why?
Cancer Vaccines
1
2007
29
0.150
Why?
Gene Expression
2
2000
756
0.150
Why?
Neoplasm Recurrence, Local
1
2010
286
0.150
Why?
Subarachnoid Hemorrhage
2
1997
28
0.150
Why?
Tumor Cells, Cultured
4
1994
863
0.150
Why?
Fibroblasts
2
2007
545
0.150
Why?
Species Specificity
1
2008
340
0.150
Why?
Mice
2
2008
6103
0.150
Why?
Infant
2
2009
2249
0.150
Why?
Interleukin-4
1
2007
154
0.150
Why?
Databases, Factual
1
2007
151
0.140
Why?
Child, Preschool
2
2009
2612
0.140
Why?
Cell Movement
2
2005
376
0.140
Why?
Age Factors
1
2009
1121
0.140
Why?
Mice, Knockout
1
2009
918
0.140
Why?
Laminin
1
2005
47
0.130
Why?
Antineoplastic Agents, Phytogenic
1
2006
39
0.130
Why?
Microcirculation
1
2005
92
0.130
Why?
Proteoglycans
1
2005
101
0.130
Why?
Drug Combinations
1
2005
151
0.130
Why?
Drug Implants
2
1994
19
0.130
Why?
RNA Interference
1
2005
140
0.130
Why?
Ischemia
1
2005
90
0.130
Why?
Biological Markers
1
2008
564
0.130
Why?
Young Adult
1
2009
1074
0.130
Why?
Neoplasm Metastasis
1
2005
229
0.120
Why?
RNA, Small Interfering
1
2005
203
0.120
Why?
Transfection
1
2007
876
0.120
Why?
Rats
4
1994
4386
0.120
Why?
Vascular Endothelial Growth Factor A
1
2005
206
0.120
Why?
Child
2
2009
4086
0.120
Why?
Cohort Studies
1
2007
969
0.120
Why?
Karnofsky Performance Status
2
2000
15
0.120
Why?
Disease Models, Animal
1
2008
973
0.110
Why?
Blotting, Western
1
2005
668
0.110
Why?
Chromatography, High Pressure Liquid
1
2003
210
0.110
Why?
Time Factors
3
2000
3201
0.110
Why?
E2F1 Transcription Factor
1
2002
2
0.110
Why?
Contact Inhibition
1
2002
4
0.110
Why?
E2F Transcription Factors
1
2002
3
0.110
Why?
Cyclin-Dependent Kinase 2
1
2002
9
0.110
Why?
Mice, Inbred C57BL
1
2008
1683
0.110
Why?
S Phase
1
2002
41
0.110
Why?
Cyclin-Dependent Kinase Inhibitor p27
1
2002
33
0.110
Why?
G1 Phase
1
2002
48
0.100
Why?
Cyclin-Dependent Kinases
1
2002
40
0.100
Why?
Proportional Hazards Models
1
2003
453
0.100
Why?
Culture Media
1
2002
196
0.100
Why?
RNA
1
2005
407
0.100
Why?
Active Transport, Cell Nucleus
1
2002
97
0.100
Why?
Tumor Suppressor Proteins
1
2002
89
0.100
Why?
Cranial Irradiation
1
2000
12
0.100
Why?
Dose Fractionation
3
2000
58
0.090
Why?
Recombinant Fusion Proteins
1
2002
382
0.090
Why?
Cell Cycle Proteins
1
2002
167
0.090
Why?
Carcinoma, Non-Small-Cell Lung
1
2000
71
0.090
Why?
Phosphatidylinositol 3-Kinases
1
2000
164
0.080
Why?
Cells, Cultured
1
2005
2563
0.080
Why?
Radiotherapy Dosage
3
1995
203
0.080
Why?
Inflammation
1
2003
550
0.080
Why?
Patient Selection
1
2000
209
0.080
Why?
Proto-Oncogene Proteins
1
2000
297
0.080
Why?
Intracranial Aneurysm
1
1997
22
0.080
Why?
Combined Modality Therapy
2
2007
486
0.070
Why?
Neurologic Examination
1
1997
142
0.070
Why?
Lung Neoplasms
1
2000
428
0.070
Why?
Prognosis
3
1997
1080
0.070
Why?
Transcription Factors
1
2002
689
0.070
Why?
Infusion Pumps, Implantable
1
1995
7
0.070
Why?
Injections, Intralesional
1
1995
12
0.070
Why?
Decanoic Acids
1
1994
5
0.060
Why?
Polyesters
1
1994
6
0.060
Why?
Clinical Trials, Phase II as Topic
1
1994
14
0.060
Why?
Biopolymers
1
1994
12
0.060
Why?
Apoptosis
1
2000
855
0.060
Why?
Tissue Distribution
1
1994
236
0.060
Why?
Dose-Response Relationship, Drug
1
1995
1138
0.050
Why?
Clinical Trials as Topic
1
1995
675
0.050
Why?
Pancreatectomy
1
2011
17
0.050
Why?
Signal Transduction
1
2000
1626
0.050
Why?
Prospective Studies
3
1997
1677
0.050
Why?
Follow-Up Studies
2
2000
1857
0.050
Why?
Epithelium
1
2011
229
0.050
Why?
Salvage Therapy
1
2009
60
0.040
Why?
Disease-Free Survival
1
2009
202
0.040
Why?
Dose-Response Relationship, Radiation
2
1995
218
0.040
Why?
Pseudopodia
1
2007
11
0.040
Why?
Feasibility Studies
1
2007
205
0.040
Why?
Neoplasm Invasiveness
1
2007
154
0.040
Why?
Survival
1
2006
4
0.030
Why?
Chemistry, Pharmaceutical
1
2006
22
0.030
Why?
Microscopy, Fluorescence
1
2007
277
0.030
Why?
Cell Communication
1
2007
141
0.030
Why?
Dogs
1
2006
488
0.030
Why?
Infant, Newborn
1
2010
1831
0.030
Why?
Magnetic Resonance Imaging
1
2010
1010
0.030
Why?
Cell Proliferation
1
2007
521
0.030
Why?
Ribonucleoprotein, U1 Small Nuclear
1
2000
1
0.020
Why?
Gliosarcoma
1
2000
4
0.020
Why?
Esophagitis
1
2000
8
0.020
Why?
Proto-Oncogene Proteins c-met
1
2000
17
0.020
Why?
Radiation Pneumonitis
1
2000
44
0.020
Why?
RNA, Catalytic
1
2000
58
0.020
Why?
Proto-Oncogene Proteins c-akt
1
2000
134
0.020
Why?
Neoplasm Staging
1
2000
335
0.020
Why?
Gene Transfer Techniques
1
2000
145
0.020
Why?
Protein-Tyrosine Kinases
1
2000
179
0.020
Why?
Regression Analysis
1
2000
524
0.020
Why?
Carcinoma, Squamous Cell
1
2000
232
0.020
Why?
Palliative Care
1
2000
159
0.020
Why?
Survival Rate
1
2000
619
0.020
Why?
Recombinant Proteins
1
2000
768
0.020
Why?
Craniotomy
1
1997
18
0.020
Why?
Adenocarcinoma
1
2000
423
0.020
Why?
Confidence Intervals
1
1997
165
0.020
Why?
Matched-Pair Analysis
1
1995
17
0.020
Why?
Length of Stay
1
1997
280
0.020
Why?
Prevalence
1
1997
541
0.020
Why?
Remission Induction
1
1995
163
0.020
Why?
Predictive Value of Tests
1
1997
601
0.020
Why?
Incidence
1
1997
679
0.020
Why?
Tumor Stem Cell Assay
1
1994
23
0.020
Why?
Medulloblastoma
1
1994
19
0.010
Why?
Cerebellar Neoplasms
1
1994
22
0.010
Why?
Severity of Illness Index
1
1997
919
0.010
Why?
Risk Factors
1
1997
2318
0.010
Why?

Visualizations


Walter's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department